Free delivery on all NHS prescriptions — order now
- Home
- Chronic Conditions
- Asthma/COPD
- AirFluSal MDI
AirFluSal MDI
Images for illustrative purposes only
AirFluSal MDI is a combination inhalation treatment used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD) containing the active ingredients salmeterol and fluticasone propionate.
- Contains both a preventer steroid and a long-acting bronchodilator for dual-action airway management
- Designed to provide continuous respiratory support for up to 12 hours with regular use
- A widely prescribed MDI (Metered Dose Inhaler) used across the NHS for chronic asthma and COPD
- Fulfilled by Mail my Meds and delivered discreetly to your door following a clinical review
More information
"AirFluSal MDI is typically prescribed as a maintenance treatment for adults living with asthma or COPD who require both an inhaled corticosteroid and a long-acting beta-agonist to keep their airways open and reduce inflammation. It is important to remember that this is a preventer inhaler intended for daily use to maintain respiratory health rather than a rescue medication for sudden attacks." - Rachael Clarke MRCPharm MFRPSI FRSPH (GPHC Number: 2061366)
You can buy AirFluSal MDI online through the Mail my Meds platform by completing a simple and convenient online consultation with a registered prescriber. Once your consultation is approved, your medication is shipped directly from our registered UK pharmacy (GPHC Number: 9011560) in discreet packaging. This process ensures you receive genuine treatment safely and efficiently without needing to visit a GP in person for every repeat.
The price of AirFluSal MDI is competitive and reflects our commitment to providing affordable access to essential respiratory care for patients in the UK. While the cost may vary depending on the strength prescribed by your clinician, we aim to provide a transparent and cost-effective service for both private and NHS prescription fulfilment.
Mail my Meds offers various reliable delivery options to ensure your AirFluSal MDI reaches you when you need it most. We provide tracked shipping across the UK, allowing you to monitor your order from our pharmacy to your doorstep. All packages are sent in plain, discreet wrapping to maintain your privacy.
AirFluSal MDI is a pressurised metered-dose inhaler used to treat chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It belongs to a class of medications known as combination inhalers, as it addresses two different aspects of lung disease: airway constriction and tissue inflammation. It is specifically designed for patients whose symptoms are not sufficiently controlled by a single steroid inhaler alone.
The active ingredients in AirFluSal MDI are salmeterol xinafoate and fluticasone propionate, which work together to improve lung function. Salmeterol is a long-acting bronchodilator that relaxes the muscles in the airways, while fluticasone is a corticosteroid that reduces swelling and irritation in the lungs. This dual approach helps prevent wheezing and shortness of breath over a 12-hour period.
Many users report that AirFluSal MDI provides a reliable way to manage daily breathing difficulties and reduces the frequency of flare-ups when used consistently. Patients often appreciate the MDI format, which can be used with a spacer device to make inhalation easier. As with any chronic treatment, consistency is the most cited factor in achieving positive long-term results.
The Patient Information Leaflet (PIL) provides essential details regarding the safe use, storage, and potential risks associated with AirFluSal MDI. You should read the PIL thoroughly before starting your treatment to understand the specific instructions for your device. A physical copy is included with every inhaler dispatched from our pharmacy.
AirFluSal MDI works by combining two different mechanisms of action to keep the small airways in the lungs open and clear. The salmeterol component acts on the beta-2 receptors in the lungs to cause muscle relaxation, while the fluticasone component prevents the release of substances that cause inflammation. Together, they ensure that air can flow more easily in and out of the lungs throughout the day and night.
To use AirFluSal MDI correctly, you must coordinate your breath with the activation of the canister to ensure the medicine reaches your lungs. Following these steps helps maximise the effectiveness of your treatment:
- Remove the mouthpiece cover and shake the inhaler vigorously.
- Breathe out fully, away from the device.
- Place the mouthpiece in your mouth and close your lips firmly around it.
- Start to breathe in slowly and deeply, then press the top of the canister to release a puff.
- Hold your breath for about 10 seconds before breathing out slowly.
- Wait roughly 30 seconds before taking a second puff if prescribed.
- Rinse your mouth with water after use to prevent throat irritation.
The standard dosage for AirFluSal MDI is typically two puffs taken twice a day, usually in the morning and evening. Your prescriber will determine the correct strength and frequency based on the severity of your asthma or COPD. You should never exceed the prescribed dose, even if you feel your symptoms are worsening. In such cases, seek medical advice immediately.
Like all medicines, AirFluSal MDI can cause side effects, although not everyone will experience them. Being aware of these helps you manage your treatment more effectively:
| Frequency | Potential Side Effects |
|---|---|
| Common | Headache, throat irritation, hoarseness, or oral thrush. |
| Uncommon | Increased heart rate, feeling shaky (tremors), or anxiety. |
| Rare | Breating difficulties immediately after use (paradoxical bronchospasm). |
AirFluSal MDI is not a rescue inhaler and should not be used to treat an acute asthma attack or sudden shortness of breath. Always keep a fast-acting reliever inhaler (like Salbutamol) with you for emergencies. You should inform your prescriber if you have a history of tuberculosis, high blood pressure, diabetes, or heart problems before starting this medication.
AirFluSal MDI is often compared to other combination inhalers like Seretide or Sirdupla because they contain the same active ingredients. While the medication inside is virtually identical, the device itself or the propellant used may differ slightly. It is frequently chosen for its cost-effectiveness and reliability in the UK healthcare system.
Can I use AirFluSal MDI with a spacer?
Yes, using a spacer device with your AirFluSal MDI is often recommended, as it helps the medicine reach deep into the lungs and reduces the risk of side effects like a sore throat or oral thrush. It is particularly helpful for those who find it difficult to time their breath with the inhaler's activation.
Is AirFluSal MDI the same as Seretide?
AirFluSal MDI is a "branded generic" version of Seretide, meaning it contains the same active ingredients (salmeterol and fluticasone) and works in the same way. Doctors often prescribe it as a clinically equivalent, more affordable alternative to the original brand.
What should I do if I miss a dose?
If you miss a dose of AirFluSal MDI, take it as soon as you remember, unless it is nearly time for your next scheduled dose. Do not take a double dose to make up for a forgotten one. Simply continue with your regular routine.
The information provided on this page is for general informational purposes only and should not replace seeking professional medical advice from a doctor or pharmacist. Always consult a healthcare professional for personalised guidance regarding your specific health condition and treatment plan.
Our content is regularly reviewed by our team of medical experts to ensure it remains up to date, accurate, and aligned with current UK clinical guidelines. We prioritise providing reliable information to help you manage your health safely.
Content last updated:

